Standard Contracts
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 20th, 2007 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agrees, as of December 20, 2007, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Neurocrine Biosciences, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • December 11th, 2017 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 11, 2017, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 16th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations • Delaware
This STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of September 12, 2024 (the “Effective Date”), by and among RA Capital Healthcare Fund, L.P., a Delaware limited partnership (the “Purchaser”), on the one hand, and Avalon Ventures XI, L.P., a Delaware limited partnership (“Avalon XI”), Avalon BioVentures I, LP, a Delaware limited partnership (“ABV I”), and Avalon BioVentures SPV I, L.P., a Delaware limited partnership (“ABV SPV” and together with Avalon XI and ABV I, the “Sellers” and each a “Seller”), on the other hand.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 13th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations • Delaware
This STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of November 8, 2024 (the “Effective Date”), by and among RA Capital Healthcare Fund, L.P. a Delaware limited partnership (the “Purchaser”), on the one hand, and Boxer Capital, LLC, a Delaware limited liability company (“Seller”), on the other hand (each a “Party”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 14, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Services-medical laboratories
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2018 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 14, 2018, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky and Rajeev Shah (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 20th, 2015 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of January 20, 2015, is by and among RA Capital Management, LLC, Peter Kolchinsky and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • December 5th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 5, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 23rd, 2016 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of December 23, 2016, is by and among RA Capital Management, LLC, Peter Kolchinsky, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • April 7th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 07, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 18th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 18, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • February 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 28th, 2016 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of July 28, 2016, is by and among RA Capital Management, LLC, Peter Kolchinsky, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • June 7th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of June 7, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 13, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., and the RA Capital Nexus Fund II, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • December 17th, 2020 • Ra Capital Management, L.P. • Services-medical laboratories
This Joint Filing Agreement, dated as of December 17, 2020, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • February 12th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 12, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 14th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • February 12th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of February 12, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • April 7th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of April 07, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • February 14th, 2024 • Ra Capital Management, L.P. • Ophthalmic goods
This Joint Filing Agreement, dated as of February 14, 2024, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • May 24th, 2011 • Ra Capital Management, LLC • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agrees, as of May 24, 2011, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Tengion, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • December 12th, 2014 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of December 12, 2014, is by and among RA Capital Management, LLC, Peter Kolchinsky and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • September 17th, 2019 • Ra Capital Management, LLC • Pharmaceutical preparations
This Joint Filing Agreement, dated as of September 17, 2019, is by and among RA Capital Management, LLC and Peter Kolchinsky (the foregoing are collectively referred to herein as the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • March 29th, 2021 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of March 29, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
AGREEMENTJoint Filing Agreement • November 5th, 2024 • Ra Capital Management, L.P. • Pharmaceutical preparations
This Joint Filing Agreement, dated as of November 5, 2024 is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).
